MedTrace Logo

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

NCT04021563 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-11-29

No results posted yet for this study

Summary

This study is to evaluate the safety, tolerability, PK of SR419 in healthy volunteers.

Conditions

  • Healthy Volunteers

Interventions

DRUG

SR419

Ascending single and multiple doses of SR419 orally

DRUG

Placebo

Ascending single and multiple doses of placebo orally

Sponsors & Collaborators

  • Syneos Health

    collaborator OTHER

  • Shanghai SIMR Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr.Hatchuel · Linear Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-26
Primary Completion
2019-12-10
Completion
2019-12-10

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021563 on ClinicalTrials.gov